Statin Use Is Associated With Improved Survival But Not Progression‐Free Outcomes in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab–Bevacizumab
Toshinori Toyota, et al. “Statin Use Is Associated With Improved Survival But Not Progression‐Free Outcomes in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab–Bevacizumab.” Hepatology Research, 2026. doi:10.1111/hepr.70232.
@article{Toyota2026,
title = {Statin Use Is Associated With Improved Survival But Not Progression‐Free Outcomes in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab–Bevacizumab},
author = {Toyota, Toshinori and Narahara, Satoshi and Uojima, Haruki and Kitano, Yuki and Mizuta, Takahiro and Maeda, Daiki and Kurano, Soutarou and Tanaka, Kentaro and Inada, Hiroki and Honda, Munenori and Yoshimaru, Yoko and Watanabe, Takehisa and Nagaoka, Katsuya and Setoyama, Hiroko and Hayashi, Hiromitsu and Suzuki, Takanori and Matsuura, Kentaro and Iwasaki, Shuichiro and Nomura, Nao and Miyase, Shiho and Yuruki, Hideto and Sakai, Yoshinari and Kudo, Koichi and Hidaka, Hisashi and Iwatsuki, Masaaki and Tanaka, Yasuhito},
journal = {Hepatology Research},
year = {2026},
doi = {10.1111/hepr.70232},
url = {https://onlinelibrary.wiley.com/doi/10.1111/hepr.70232?af=R}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...